Cite

HARVARD Citation

    Lightner, A. et al. (2020). Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas. Inflammatory bowel diseases. 26 (5), pp. 670-677. [Online]. 
  
Back to record